Your browser doesn't support javascript.
loading
Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy.
Takamatsu, Kimiharu; Tanaka, Nobuyuki; Hakozaki, Kyohei; Takahashi, Ryohei; Teranishi, Yu; Murakami, Tetsushi; Kufukihara, Ryohei; Niwa, Naoya; Mikami, Shuji; Shinojima, Toshiaki; Sasaki, Takashi; Sato, Yusuke; Kume, Haruki; Ogawa, Seishi; Kakimi, Kazuhiro; Kamatani, Takashi; Miya, Fuyuki; Tsunoda, Tatsuhiko; Aimono, Eriko; Nishihara, Hiroshi; Sawada, Kazuaki; Imamura, Takeshi; Mizuno, Ryuichi; Oya, Mototsugu.
Afiliación
  • Takamatsu K; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Tanaka N; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan. urotanaka@keio.jp.
  • Hakozaki K; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Takahashi R; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Teranishi Y; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Murakami T; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Kufukihara R; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Niwa N; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Mikami S; Department of Diagnostic Pathology, Keio University Hospital, 160-8582, Tokyo, Japan.
  • Shinojima T; Department of Urology, Keio University School of Medicine, 160-8582, Tokyo, Japan.
  • Sasaki T; Department of Urology, Saitama Medical University, Moroyama, Saitama, Japan.
  • Sato Y; Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Kume H; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ogawa S; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kakimi K; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kamatani T; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan.
  • Miya F; Laboratory for Medical Science Mathematics, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
  • Tsunoda T; Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Aimono E; Department of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nishihara H; Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Sawada K; Laboratory for Medical Science Mathematics, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
  • Imamura T; Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Mizuno R; Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Oya M; Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Nat Commun ; 12(1): 5547, 2021 09 20.
Article en En | MEDLINE | ID: mdl-34545095

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Receptores Inmunológicos / Antígenos CD / Receptor 2 Celular del Virus de la Hepatitis A / Neoplasias Renales Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Receptores Inmunológicos / Antígenos CD / Receptor 2 Celular del Virus de la Hepatitis A / Neoplasias Renales Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article